Adaptimmune Therapeutics shares owned by Diametric Capital
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Diametric Capital
from 13F filings
Historical chart of Diametric Capital investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Diametric Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $73k | 78k | 0.93 |